Clinical Trial Update: Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years [Phase 3]

View source ↗

Summary

Phase 3 multi-center trial evaluating DSMM for newly diagnosed multiple myeloma in patients up to 60 years old.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DSMM

Snippet

Sponsor: University of Wuerzburg | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN